← Evidence map

ArticleClinical pharmacokinetics2023

Pharmacokinetics, Safety, and Tolerability of Glepaglutide, a Long-Acting GLP-2 Analog, in Subjects with Renal Impairment.

Mikkel Askjær Agersnap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023
2024
2025
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 36811175